Earnings Call · Q1 FY2025·2025-05-12

Q1 25EPS +19.39%·Rev n/aQ4 24EPS +9.26%·Rev n/aQ3 24EPS -36.14%·Rev n/aQ2 24EPS -18.57%·Rev n/a⚠ consensus missing

Mineralys Therapeutics, Inc. MLYS

Dan Ferry — Unknown

Jon Congleton — Chief Executive Officer

Dave Rodman — Chief Medical Officer

Adam Levy — Chief Financial Officer

+1.2%1d on move date+0.5% vs SPY3d+2.3%5d+2.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MLYS calls or request research access.

More MLYS calls Browse calls Request research access